ArchIntel

JUNE 9, 2021

Earlier in his career, Fields worked as a conference and marketing coordinator at EBD Group, an organizer of biotech and medical device events. He joined Bell Labs in 1977 and held multiple leadership roles, including director of convergence strategy and global marketing.

Competitive 104

Competitive Competitive Intelligence Biotech Profiling 104

Fuld

NOVEMBER 1, 2022

BOSTON – Nov 1, 2022 – Fuld & Company, a fast-growing research, analytics, and advisory business, today announced the appointment of Brad Thompson to the role of Advisory Board Member. Joining Fuld & Company is an exciting opportunity for me to work with global leaders in research, analytics, and intelligence ,” says Brad.

Pharmaceutical 52

Pharmaceutical Biotech Competitive Intelligence Competitive 52

Alpha Sense BI

APRIL 29, 2024

This staggering statistic is representative of a transformative shift in the asset management space away from archaic research methods. Generative AI in venture capital streamlines workflows, reduces research and due diligence blind spots, and surfaces qualitative and quantitative insights to make data-driven decisions faster.

Capital 52

Capital Due Diligence Biotech Startups 52

Alpha Sense BI

APRIL 19, 2024

On the other hand, 2022 and 2023 brought mass layoffs , falling market capitalizations, and a weakening of global tech spending. In fact, projections for the global spatial computing market are valued at $269.8 Over the past few years, the technology industry has experienced dramatic highs and lows. billion by 2030 with a CAGR of 23.1%

Technology 69

Technology Technology Retail Due Diligence 69

Alpha Sense BI

MARCH 13, 2024

According to PwC’s Annual Global CEO survey, 54% of healthcare industry CEOs intend to make at least one acquisition in the next three years. According to an outlook published by PwC , “large-cap pharma companies are expected to continue pursuing mid-sized biotech companies to fill pipeline gaps in the face of impending patent cliffs.

Pharmaceutical 59

Pharmaceutical Hospitals Due Diligence Biotech 59

Alpha Sense BI

MARCH 28, 2023

These first-hand perspectives are a critical addition to the secondary research that most professionals rely on in their market research, landscaping, and monitoring. Some are equipped with artificial intelligence capabilities that enable you to maximize and streamline your research, while others are more traditional in their approach.

Value Chain 52

Value Chain Biotech Research Competitive 52

Engage3

MAY 19, 2022

He has a wealth of cross-industry experience in accelerating companies’ growth and raising capital, having spent more than fifteen years in SaaS companies as CFO and COO in industries as varied as manufacturing and biotech. He received his Bachelor of Arts in Economics and Political Science from Williams College. Bryan Courtney- Bennett Sr.

Retail 52

Retail Capital Finance Biotech 52

Alpha Sense BI

JANUARY 25, 2023

Over the last three years, the COVID-19 pandemic brought new energy to manufacturing vaccines for a myriad of global diseases and health conditions. Using the AlphaSense platform, we dug deep into new drug research and development areas that will likely shape the 2023 vaccine market. a potential cure for skin cancer.

Biotech 96

Biotech Pharmaceutical Hospitals Market Intelligence 96

Netbasequid

FEBRUARY 22, 2021

And they used NetBase Quid to inform their research. We’ll provide a high-level summary here, and some practical applications of frameworks they’ve used that could apply to powering your own research on any number of topics. The global tech industry is projected to hit $5T in 2021 , which would represent a 4.2% With 6,415.

Biotech 98

Biotech Innovation Intellectual Property Market Research 98

Alpha Sense BI

JANUARY 26, 2024

Attracting industry leaders, emerging fast-growth companies, and technology creators from around the world, life science corporations share their latest advances, leading research, and best practices—as well as their intentions to scale their digital health solutions—to the masses in hopes of securing capital.

Biotech 59

Biotech Research Loss Algorithm 59

Sedulo

MARCH 15, 2023

Our analysis of global data gathered from multiple trial registries provided a compelling snapshot of the recent IO clinical landscape and prompted several unanswered questions regarding future evolution and the impact on manufacturers competing in the space. Assess and benchmark enrollment timing. Monitor key activity within the landscape.

Biotech 52

Biotech Competitive Landscape Pharmaceutical Benchmarking 52

Happy Market

MAY 9, 2022

Founded in 2007, Civic Science is a consumer intelligence research platform that polls millions of Americans each week covering thousands of topics. HubUX is a research operation platform for private panel management, qualitative automation including video audition questions, and surveys. Happy Researching! ??. [00:00:00].

Management 52

Management Entertainment Market Research Marketing Research 52

ATTEST

NOVEMBER 22, 2024

Boston’s innovation business ecosystem—from biotech startups in Kendall Square to fintech firms downtown—relies heavily on quality consumer insights. But with so many options for market research, from traditional focus group facilities to modern research platforms, finding the right partner isn’t always straightforward.

Marketing Research 52

Marketing Research Market Research Research Marketing 52

Alpha Sense BI

MARCH 14, 2025

While lingering concerns around tariffs and global policy pose macroeconomic uncertainty, experts widely agree that 2025 will mark a widespread return to IPO and deal activity , following years of low activity. If you are a GSK or a Pfizer or even an even smaller start-up biotech , exactly the same criteria is applied across.

Capital 59

Capital Biotech Startups Finance 59

ATTEST

DECEMBER 20, 2024

From biotech startups in Torrey Pines to craft breweries in North Park, San Diego businesses rely on solid consumer insights to guide their decisions. The city has some well-establised traditional local agencies and modern research companies, each with their own expertise. Attest approaches market research differently.

Marketing Research 52

Marketing Research Market Research Research Marketing 52

Alpha Sense BI

FEBRUARY 6, 2025

In 2024, global M&A volume reached $3.4 North America led global M&A activity with 50% of deal volume, followed by EMEA at 25% and APAC at 22%. The tech sector accounted for 19% of global deal volume, followed by healthcare at 10% and finance at 9%. trillion seen in 2021. Novo Holdings Acquisition of Catalent: $16.5

Biotech 59

Biotech Capital Pharmaceutical Finance 59

Alpha Sense BI

NOVEMBER 9, 2022

billion), restructuring expense at ~$800 million (was $600 million) and global tax rate at ~23% (was 24%), while short-term incentive compensation expense is expected at ~$1.6 M&A IPOs to watch in Pharma and Biotech. Adjusted operating margin is expected to be strong as pricing should offset manufacturing costs in Q4. JOYY Inc. [YY].

Sales 52

Sales Loss Capital Biotech 52

CIO

MARCH 4, 2025

As a business executive who has led ventures in areas such as space technology or data security and helped bridge research and industry, Ive seen first-hand how rapidly deep tech is moving from the lab into the heart of business strategy. For example, generative AI went from research milestone to widespread business adoption in barely a year.

Technology 442

Technology Technology Biotech Business 442

Alpha Sense BI

APRIL 3, 2025

Concurrently, smaller biotech firms and midsized companies offering promising innovations, particularly in high-demand therapeutic areas such as oncology, immunology, neuroscience, and cardio-metabolic conditions, are expected to become highly attractive targets. How will tariff policies play out?

Biotech 59

Biotech Pharmaceutical Loss Research 59

Alpha Sense BI

JANUARY 8, 2025

In this blog, we leverage proprietary expert interviews from the AlphaSense market research platform to understand the top trends shaping the healthcare landscape in 2025. Director with a large managed care organization Biotech and Pharma The Trump administration is expected to bring a relaxation of antitrust enforcement. Kennedy Jr.

Innovation 69

Innovation Biotech Pharmaceutical Benchmarking 69